Dr. Martin R. Back, MD

Dr. Back practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Back's NPI, 1962414342, was assigned on August 13, 2006. Dr. Back graduated from David Geffen School of Medicine at UCLA in 1990. Dr. Back holds Florida license ME71212.

Dr. Back's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Back's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. Dr. Back is also affiliated with UF Health Flagler Hospital. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Back to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Back practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Back's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Back is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Back's licenses on file in 2 states: Florida and California.

Dmand AI lists amputation, arterial blot clot /embolism, carotid revascularization, chronic skin ulcer, circulatory problems in extremities, deep vein thrombosis (DVT), heart device and aorta surgery and leg revascularization among the conditions Dr. Back treats.

CMS data shows 765 Medicare services from Dr. Back across 17 procedure codes in 2024, for 561 Medicare patients. Medicare paid $52,807 for them.

CMS counts 561 Medicare patients who saw Dr. Back in 2024. The largest group is 65 to 74, with 230 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Back's median patient age at 73, with 45% women.

In 2024, Dr. Back wrote 165 Medicare Part D claims for 76 patients. 87% of them were for generic drugs. CMS names the drug for 86 of them, across 5 drugs with 11 or more claims each, at $1,337 in total drug cost. In 2023, CMS named 63 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Back for performance year 2024, reported individually. Dr. Back accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of leg revascularization (restoring blood flow) by Dr. Back, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 131 papers to Dr. Back, published from 2002 to 2025. 2017 was the busiest year, with 9. The most frequent topics are Blood Vessel Prosthesis Implantation, Endovascular Procedures and Postoperative Complications. Dr. Back has published most often in J Vasc Surg. Dr. Back's most frequent co-authors are Brad L. Johnson, MD, Dennis Francis Bandyk, MD and Thomas S. Huber, MD, PhD.

Dmand AI links Dr. Back to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Aortic Aneurysm, Abdominal and Aortic Aneurysm.

CMS Open Payments shows 169 general payments to Dr. Back from 6 drug and device companies from 2016 to 2025. Education speaker fees make up the largest share, 26% of the total. Cook Medical LLC paid the most, $46,397.

Dmand AI lists 2 awards for Dr. Back, most recently ACS Fellow in 2012.

Dr. Back graduated from David Geffen School of Medicine at UCLA in 1990. Dr. Back is a member of ACS and SLS.

Dr. Back is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.